Latest News in the pharma Industry
All
Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development
1 Sep 2020
Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of India Pvt. Ltd. (Serum), the world’s largest vaccine ma...
Read more
Aragen Bioscience announces the appointment of Steven Lang, PHD, MBA as Vice President, Biologics
1 Sep 2020
Aragen Bioscience is pleased to announce the appointment of Dr. Steven Lang as Vice President, Biologics. Aragen, a wholly-owned subsidiary of GVK BIO, is a leading Contract Research Organization focused on accelerating biologics product development wi...
Read more
Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia
1 Sep 2020
Aragen Bioscience, Inc, a fully owned subsidiary of GVK BIO and a leading large molecule CRO, and University of Technology Sydney (UTS), the top-ranked young university in Australia, are pleased to announce a collaboration to accelerate biologics R&D i...
Read more
Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process
1 Sep 2020
Full Service “Sequence-to-Manufacturing” Offering Designed to Drive Efficiencies and Reduce Overall Timelines for Delivering Early-Stage CGMP Bulk Drug Substances
Read more
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
1 Sep 2020
Oragenics, Inc. (NYSE American: OGEN), (the “Company” or “Oragenics”), today announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an agreement with Aragen Bioscience, a leading contract research organization focused o...
Read more
KORSCH introduces next-generation mid-range tablet press
1 Sep 2020
X 3 Tablet Press incorporates production capabilities and versatility traditionally limited to large-scale production machines.
Read more
Development of rapid novel SARS-CoV-2 diagnostics started
1 Sep 2020
Enzyme specialists from EUCODIS Bioscience and diagnostics experts from Biosynth-Carbosynth have teamed up to develop a novel diagnostic tool for the fast and reliable detection of an acute SARS-CoV-2 infection. Based on viral enzymatic activities and ...
Read more
Vaccine Testing to Ensure Successful and Faster Vaccine Research and Development
1 Sep 2020
Following its emergence earlier this year, the novel coronavirus (SARS-CoV-2) has spread rapidly and snowballed into a pandemic. Everyone – citizens, businesses, and governments – yearns for life to go back to normal soon.
Read more
Managing Your Life Sciences Quality Management System Remotely
1 Sep 2020
Telecommuting and online commerce has been with us for some time and works seamlessly in many industries, but the current state of events has forced companies to apply remote management to other areas that have historically been considered "hands-on" j...
Read more
SGS Signs Analytical Testing Agreement with AstraZeneca for COVID-19 Vaccine Candidate
1 Sep 2020
SGS is pleased to announce the signing of an agreement with AstraZeneca for the provision of safety, quality control and analytical testing services in support of AZD1222 – a COVID-19 vaccine candidate co-invented by the University of Oxford and its sp...
Read more
SGS Joins Oxford University Consortium Led by the Jenner Institute to Develop COVID-19 Vaccine
1 Sep 2020
In a consortium led by the Jenner Institute, Oxford University, SGS has joined forces with specialists in infectious diseases, research and innovation, and pharmaceuticals to rapidly develop, scale-up and produce a potential vaccine called ChAdOx1 nCov...
Read more
Mylan and Biocon Biologics launch Lantus biosimilar in the US
1 Sep 2020
Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market.
Read more